Published in Br J Rheumatol on July 01, 1992
The localized scleroderma skin severity index and physician global assessment of disease activity: a work in progress toward development of localized scleroderma outcome measures. J Rheumatol (2009) 1.35
The EUSTAR model for teaching and implementing the modified Rodnan skin score in systemic sclerosis. Ann Rheum Dis (2007) 1.08
Interobserver reliability in measuring flexion, internal rotation, and external rotation of the hip using a plurimeter. Ann Rheum Dis (1996) 1.05
Non-invasive measurement of biomechanical skin properties in systemic sclerosis. Ann Rheum Dis (2002) 0.91
Longitudinal development of skin involvement and reliability of high frequency ultrasound in systemic sclerosis. Ann Rheum Dis (2004) 0.91
Circulating gamma/delta T lymphocytes from systemic sclerosis (SSc) patients display a T helper (Th) 1 polarization. Clin Exp Immunol (2001) 0.86
The development of a structured rating schedule (the BAS) to assess skills in breaking bad news. Br J Cancer (1999) 0.83
Reliability of skin score in scleroderma. Br J Rheumatol (1993) 0.82
Irritable bowel syndrome and organic diseases: a comparative analysis of esophageal motility. World J Gastroenterol (2013) 0.77
Spontaneous skin regression and predictors of skin regression in Thai scleroderma patients. Clin Rheumatol (2011) 0.76
Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol (1988) 16.45
The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum (1996) 6.88
The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int (2007) 6.44
Statistical methods for assessing observer variability in clinical measures. BMJ (1992) 6.24
Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int (2005) 5.54
A meta-analysis of previous fracture and subsequent fracture risk. Bone (2004) 4.92
EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis (2006) 4.83
The prevalence of rheumatoid arthritis in the United Kingdom: new estimates for a new century. Rheumatology (Oxford) (2002) 3.87
EULAR evidence-based recommendations for the management of fibromyalgia syndrome. Ann Rheum Dis (2007) 3.70
Diagnosis and clinical manifestations of bacterial vaginosis. Am J Obstet Gynecol (1988) 3.66
Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte. Nat Immunol (2000) 3.58
Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist. Arthritis Rheum (2004) 3.46
EULAR recommendations for the management of Behçet disease. Ann Rheum Dis (2008) 3.37
The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus. Q J Med (1993) 3.35
The prevalence of chronic widespread pain in the general population. J Rheumatol (1993) 3.29
Smoking and fracture risk: a meta-analysis. Osteoporos Int (2004) 3.08
Survival with first-line bosentan in patients with primary pulmonary hypertension. Eur Respir J (2005) 2.83
A controlled trial of azathioprine in Behçet's syndrome. N Engl J Med (1990) 2.77
Measurement of shoulder related disability: results of a validation study. Ann Rheum Dis (1994) 2.70
Are US populations appropriate for trials of human immunodeficiency virus vaccine? The HIVNET Vaccine Preparedness Study. Am J Epidemiol (2001) 2.69
Hydralazine-induced systemic lupus erythematosus: influence of HLA-DR and sex on susceptibility. Lancet (1980) 2.63
Population health and health care use: an information system for policy makers. Milbank Q (1996) 2.54
The clinical course of shoulder pain: prospective cohort study in primary care. Primary Care Rheumatology Society Shoulder Study Group. BMJ (1996) 2.53
Novel thioether bond revealed by a 1.7 A crystal structure of galactose oxidase. Nature (1991) 2.48
BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus erythematosus. Rheumatology (Oxford) (2005) 2.37
Projecting the need for hip replacement over the next three decades: influence of changing demography and threshold for surgery. Ann Rheum Dis (1999) 2.36
Career differences between primary care and traditional trainees in internal medicine and pediatrics. Ann Intern Med (1992) 2.28
Resolution of the identity of certain antigen-antibody systems in systemic lupus erythematosus and Sjögren's syndrome: an interlaboratory collaboration. Arthritis Rheum (1979) 2.19
Nonketotic diabetes mellitus: insulin deficiency or insulin resistance? Am J Med (1976) 2.13
Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: A National Heart, Lung, and Blood Institute collaborative study. Hepatology (2001) 2.13
Development and assessment of a computerized index of clinical disease activity in systemic lupus erythematosus. Members of the British Isles Lupus Assessment Group (BILAG). Q J Med (1988) 2.09
Clinical effectiveness and cost-effectiveness of different models of managing long-term oral anticoagulation therapy: a systematic review and economic modelling. Health Technol Assess (2007) 2.06
Accuracy of electoral registers and Family Practitioner Committee lists for population studies of the very elderly. J Epidemiol Community Health (1989) 1.95
Overreporting voting: why it happens and why it matters. Public Opin Q (2001) 1.87
Atherosclerotic vascular events in a multinational inception cohort of systemic lupus erythematosus. Arthritis Care Res (Hoboken) (2010) 1.84
Health and exposures of United Kingdom Gulf war veterans. Part I: The pattern and extent of ill health. Occup Environ Med (2001) 1.84
Treatment of systemic sclerosis with autologous haemopoietic stem cell transplantation. Lancet (1997) 1.76
Cultivar-specific avirulence and virulence functions assigned to avrPphF in Pseudomonas syringae pv. phaseolicola, the cause of bean halo-blight disease. EMBO J (2000) 1.76
Population study of tender point counts and pain as evidence of fibromyalgia. BMJ (1994) 1.71
A new approach to the development of assessment guidelines for osteoporosis. Osteoporos Int (2002) 1.70
Estimating the incidence of systemic lupus erythematosus in a defined population using multiple sources of retrieval. Br J Rheumatol (1990) 1.70
The polarized light method for the study of myelin degeneration as compared with the Marchi and Sudan III methods. Am J Pathol (1939) 1.69
Relationship between symptoms and disordered continence mechanisms in women with idiopathic faecal incontinence. Gut (2005) 1.67
The British Society for Rheumatology biologics register. Ann Rheum Dis (2005) 1.66
HLA and rheumatoid arthritis: a combined analysis of 440 British patients. Ann Rheum Dis (1986) 1.66
Accumulation of coronary artery disease risk factors over three years: data from an international inception cohort. Arthritis Rheum (2008) 1.65
The development of model curricula for Health Informatics. Stud Health Technol Inform (2001) 1.65
Is rheumatoid arthritis becoming less severe? J Chronic Dis (1983) 1.64
Variation in indications for cataract surgery in the United States, Denmark, Canada, and Spain: results from the International Cataract Surgery Outcomes Study. Br J Ophthalmol (1998) 1.64
HIV infection among lower socioeconomic strata prostitutes in Nairobi. AIDS (1990) 1.62
A randomised controlled trial of a community intervention to prevent adolescent tobacco use. Tob Control (2000) 1.62
Teaching rheumatology to medical students: current practice and future aims. J R Coll Physicians Lond (1992) 1.62
Quantifying the exact role of HLA-DRB1 alleles in susceptibility to inflammatory polyarthritis: results from a large, population-based study. Arthritis Rheum (1999) 1.61
HrpZ(Psph) from the plant pathogen Pseudomonas syringae pv. phaseolicola binds to lipid bilayers and forms an ion-conducting pore in vitro. Proc Natl Acad Sci U S A (2001) 1.59
HLA-DRB1*0401/0404 genotype and rheumatoid arthritis: increased association in men, young age at onset, and disease severity. J Rheumatol (1995) 1.58
Female phenotype and multiple abnormalities in sibs with a Y chromosome and partial X chromosome duplication: H--Y antigen and Xg blood group findings. J Med Genet (1980) 1.56
Mutational spectrum of the CHAC gene in patients with chorea-acanthocytosis. Eur J Hum Genet (2002) 1.56
Clinical validation of an autoantibody test for lung cancer. Ann Oncol (2010) 1.55
Relapse prevention by means of paroxetine in ECT-treated patients with major depression: a comparison with imipramine and placebo in medium-term continuation therapy. Acta Psychiatr Scand (1996) 1.55
Factor VIII related antigen in connective tissue disease patients and relatives. Br J Rheumatol (1990) 1.55
Incidence and prevalence of chlamydia, herpes, and viral hepatitis in a homeless adolescent population. Sex Transm Dis (2001) 1.54
An experiment to test the feasibility of integrating occupational health services into an HMO. J Public Health Policy (1981) 1.54
Association between insulin-like growth factor status and physical activity levels in rheumatoid arthritis. J Rheumatol (2001) 1.53
Detection of hypoxia in human squamous cell carcinoma by EF5 binding. Cancer Res (2000) 1.53
The epidemiology of vertebral fractures. European Vertebral Osteoporosis Study Group. Bone (1993) 1.53
Pelvic insufficiency fractures in rheumatoid arthritis. Br J Rheumatol (1993) 1.52
Angiotensin convertase activities in human alveolar macrophages: effects of cigarette smoking and sarcoidosis. Science (1979) 1.52
International applicability of the VF-14. An index of visual function in patients with cataracts. Ophthalmology (1997) 1.51
The clinical significance of autoantibodies to a soluble cytoplasmic antigen in systemic lupus erythematosus and other connective tissue diseases. J Rheumatol (1979) 1.51
Marfan Database (third edition): new mutations and new routines for the software. Nucleic Acids Res (1998) 1.49
Human immunodeficiency virus type 1 mRNA expression in peripheral blood cells predicts disease progression independently of the numbers of CD4+ lymphocytes. Proc Natl Acad Sci U S A (1994) 1.48
Systemic lupus erythematosus in childhood. Ann Rheum Dis (1981) 1.48
Health and exposures of United Kingdom Gulf war veterans. Part II: The relation of health to exposure. Occup Environ Med (2001) 1.45
Fanconi anemia in black African children. Am J Med Genet (1990) 1.44
A potent far-upstream enhancer in the mouse pro alpha 2(I) collagen gene regulates expression of reporter genes in transgenic mice. J Cell Biol (1996) 1.42
Antiarrhythmic drug therapy in the Multicenter UnSustained Tachycardia Trial (MUSTT): drug testing and as-treated analysis. J Am Coll Cardiol (2001) 1.42
Maternal-fetal HLA incompatibility and the course of inflammatory arthritis during pregnancy. J Rheumatol (2000) 1.41
TATA-binding protein residues implicated in a functional interplay between negative cofactor NC2 (Dr1) and general factors TFIIA and TFIIB. J Biol Chem (1995) 1.41
Dysregulation of transforming growth factor beta signaling in scleroderma: overexpression of endoglin in cutaneous scleroderma fibroblasts. Arthritis Rheum (2002) 1.40
Patients' acceptance of waiting for cataract surgery: what makes a wait too long? Soc Sci Med (1997) 1.39
Magnetic resonance imaging of osteitis condensans ilii. Br J Rheumatol (1994) 1.39
Systemic lupus erythematosus in an adult population in southern Sweden: incidence, prevalence and validity of ARA revised classification criteria. Br J Rheumatol (1985) 1.38
Malabsorption caused by coeliac disease in patients who have scleroderma. Br J Rheumatol (1995) 1.38
Visual outcomes of cataract surgery in the United States, Canada, Denmark, and Spain. Report From the International Cataract Surgery Outcomes Study. Arch Ophthalmol (1998) 1.38
Baseline comorbidity levels in biologic and standard DMARD treated patients with rheumatoid arthritis: results from a national patient register. Ann Rheum Dis (2005) 1.36
Sensitivity to change of 3 Systemic Lupus Erythematosus Disease Activity Indices: international validation. J Rheumatol (1994) 1.35
The performance of anti-cyclic citrullinated peptide antibodies in predicting the severity of radiologic damage in inflammatory polyarthritis: results from the Norfolk Arthritis Register. Arthritis Rheum (2007) 1.35
Preliminary core set of domains and reporting requirements for longitudinal observational studies in rheumatology. J Rheumatol (1999) 1.35
Using the American Medical Association physician masterfile to measure physician supply in small towns. J Rural Health (2000) 1.35
Crosscultural validation and reliability of 3 disease activity indices in systemic lupus erythematosus. J Rheumatol (1992) 1.34
Factors predicting death, survival and functional outcome in a prospective study of early rheumatoid disease over fifteen years. Br J Rheumatol (1993) 1.34
Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus Type 1 vaccine with or without gp120: a phase 2 study in higher- and lower-risk volunteers. J Infect Dis (2001) 1.34
LKB1/KRAS mutant lung cancers constitute a genetic subset of NSCLC with increased sensitivity to MAPK and mTOR signalling inhibition. Br J Cancer (2009) 1.33
The mode selection trial (MOST) in sinus node dysfunction: design, rationale, and baseline characteristics of the first 1000 patients. Am Heart J (2000) 1.33
Management of Behçet disease: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for the management of Behçet disease. Ann Rheum Dis (2008) 1.32
Serology of Lyme disease. Lancet (1986) 1.32
The use of multiple sites for the diagnosis of osteoporosis. Osteoporos Int (2006) 1.31